These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
949 related items for PubMed ID: 30857415
1. Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis via NF-κB-NFATc1 signal pathway. Yang J, Tang R, Yi J, Chen Y, Li X, Yu T, Fei J. FASEB J; 2019 Jun; 33(6):7261-7273. PubMed ID: 30857415 [Abstract] [Full Text] [Related]
2. Scutellarin inhibits RANKL-mediated osteoclastogenesis and titanium particle-induced osteolysis via suppression of NF-κB and MAPK signaling pathway. Zhao S, Sun Y, Li X, Wang J, Yan L, Zhang Z, Wang D, Dai J, He J, Wang S. Int Immunopharmacol; 2016 Nov; 40():458-465. PubMed ID: 27728897 [Abstract] [Full Text] [Related]
4. The protective effect of WKYMVm peptide on inflammatory osteolysis through regulating NF-κB and CD9/gp130/STAT3 signalling pathway. Hu J, Li X, Chen Y, Han X, Li L, Yang Z, Duan L, Lu H, He Q. J Cell Mol Med; 2020 Jan; 24(2):1893-1905. PubMed ID: 31837208 [Abstract] [Full Text] [Related]
5. Artesunate inhibits RANKL-induced osteoclastogenesis and bone resorption in vitro and prevents LPS-induced bone loss in vivo. Wei CM, Liu Q, Song FM, Lin XX, Su YJ, Xu J, Huang L, Zong SH, Zhao JM. J Cell Physiol; 2018 Jan; 233(1):476-485. PubMed ID: 28294321 [Abstract] [Full Text] [Related]
6. Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis. Zhu X, Gao J, Ng PY, Qin A, Steer JH, Pavlos NJ, Zheng MH, Dong Y, Cheng TS. J Bone Miner Res; 2016 Mar; 31(3):560-72. PubMed ID: 26363136 [Abstract] [Full Text] [Related]
11. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. Wu X, Li Z, Yang Z, Zheng C, Jing J, Chen Y, Ye X, Lian X, Qiu W, Yang F, Tang J, Xiao J, Liu M, Luo J. J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253 [Abstract] [Full Text] [Related]
12. Nirogacestat suppresses RANKL-Induced osteoclast formation in vitro and attenuates LPS-Induced bone resorption in vivo. Chen X, Chen X, Zhou Z, Mao Y, Wang Y, Ma Z, Xu W, Qin A, Zhang S. Exp Cell Res; 2019 Sep 01; 382(1):111470. PubMed ID: 31211955 [Abstract] [Full Text] [Related]
18. Protocatechualdehyde inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclastogenesis and attenuates lipopolysaccharide-induced inflammatory osteolysis. Huang H, Jiang W, Hong K, Cai J, He Y, Ma X, Wu P, Lang J, Ma Y, Huang C, Yuan J. Phytother Res; 2021 Jul 01; 35(7):3821-3835. PubMed ID: 33778997 [Abstract] [Full Text] [Related]
19. Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades. Song F, Wei C, Zhou L, Qin A, Yang M, Tickner J, Huang Y, Zhao J, Xu J. J Cell Physiol; 2018 Feb 01; 233(2):1723-1735. PubMed ID: 28681916 [Abstract] [Full Text] [Related]